Le Centre hospitalier universitaire d'Angers est un centre hospitalier universitaire français qui emploie près de 6 700 personnels hospitaliers dont plus de 1 200 personnels médicaux et pharmaceutiques.

During the past decade, CHU ANGERS - Maladies du sang conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU ANGERS - Maladies du sang" #1 collaborator was "Acute Leukemia French Association" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator, "French Intergroup of Myeloproliferative syndromes" with 1 trials as a collaborator and "Group for Research in Adult Acute Lymphoblastic Leukemia" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "CHU ANGERS - Maladies du sang" are "Acute Myeloid Leukemia" (4 trials), "Myelodysplastic Syndromes" (3 trials), "AML" (1 trials), "Acute Lymphoblastic Leukemia" (1 trials) and "Acute Myeloblastic Leukemia" (1 trials). Many other conditions were trialed in "CHU ANGERS - Maladies du sang" in a lesser frequency.

Most popular intervention types in "CHU ANGERS - Maladies du sang" are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ASTX727" (1 trials), "Blinatumomab" (1 trials), "CC-5013" (1 trials) and "CPX-351" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU ANGERS - Maladies du sang" are 11 trials for "All" genders.

Currently, there are NaN active trials in "CHU ANGERS - Maladies du sang". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in CHU ANGERS - Maladies du sang, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU ANGERS - Maladies du sang, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".